血管免疫母细胞性T细胞淋巴瘤
CD8型
癌症研究
克隆(Java方法)
生物
恶性肿瘤
人口
质量细胞仪
免疫系统
免疫学
肿瘤微环境
淋巴瘤
T细胞
表型
医学
遗传学
基因
环境卫生
作者
Joshua C. Pritchett,Zhi-Zhang Yang,Hyo Jin Kim,José C. Villasboas,Xinyi Tang,Shahrzad Jalali,James R. Cerhan,Andrew L. Feldman,Stephen M. Ansell
出处
期刊:Leukemia
[Springer Nature]
日期:2021-07-06
卷期号:36 (1): 165-176
被引量:23
标识
DOI:10.1038/s41375-021-01321-2
摘要
Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive lymphoid malignancy associated with a poor clinical prognosis. The AITL tumor microenvironment (TME) is unique, featuring a minority population of malignant CD4+ T follicular helper (TFH) cells inter-mixed with a diverse infiltrate of multi-lineage immune cells. While much of the understanding of AITL biology to date has focused on characteristics of the malignant clone, less is known about the many non-malignant populations that comprise the TME. Recently, mutational consistencies have been identified between malignant cells and non-malignant B cells within the AITL TME. As a result, a significant role for non-malignant populations in AITL biology has been increasingly hypothesized. In this study, we have utilized mass cytometry and single-cell transcriptome analysis to identify several expanded populations within the AITL TME. Notably, we find that B cells within the AITL TME feature decreased expression of key markers including CD73 and CXCR5. Furthermore, we describe the expansion of distinct CD8+ T cell populations that feature an exhausted phenotype and an underlying expression profile indicative of dysfunction, impaired cytotoxicity, and upregulation of the chemokines XCL2 and XCL1.
科研通智能强力驱动
Strongly Powered by AbleSci AI